FMR LLC's Form 4 filing
Sana Biotechnology, Inc. (SANA) · filed Jan 10, 2025
- Accession no.
- 0000950170-25-004052
- Filed
- Jan 10, 2025
- Trade date
- Jan 8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.89M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| FMR LLCCIK 0000315066 | 10% Owner, Other: See Remark 1 |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | Common Stock | SSaleDisposed | −100,000 | $6.11 | −$611,000 | 4,732,423 | Indirect | |
| Jan 8, 2025 | Common Stock | SSaleDisposed | −25,000 | $6.50 | −$162,500 | 4,707,423 | Indirect | |
| Jan 8, 2025 | Common Stock | SSaleDisposed | −164,912 | $6.71 | −$1,106,559.52 | 4,542,511 | Indirect | |
| Jan 8, 2025 | Common Stock | SSaleDisposed | −1,000 | $7.26 | −$7,260 | 4,541,511 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.